Strength Training Prevents Hyperinsulinemia, Insulin Resistance, and Inflammation Independent of Weight Loss in Fructose-Fed Animals

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Botezelli, José D ^a   Coope, Andressa ^a   Ghezzi, Ana C ^a   Cambri, Lucieli T ^b   Moura, Leandro P ^a   Scariot, Pedro P M ^a   Gaspar, Rodrigo Stellzer ^a   Mekary, Rania A ^c,d   Ropelle, Eduardo Rochete ^a   Pauli, José Rodrigo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^c MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE;

ADMINISTRATION AND DOSAGE; ANIMAL; ANIMAL EXPERIMENT; BLOOD; BODY WEIGHT LOSS; CARBOHYDRATE DIET; GLUCOSE BLOOD LEVEL; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INSULIN RESISTANCE; LIVER; MALE; METABOLIC DISORDER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RAT; RESISTANCE TRAINING; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; DIETARY CARBOHYDRATES; FRUCTOSE; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INSULIN RESISTANCE; LIVER; MALE; METABOLIC DISEASES; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; RESISTANCE TRAINING; WEIGHT LOSS;

EID: 84982682242     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31106     Document Type: Article

References (60)

1. Reaven, G. M. Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome. Cell Metab. 1, 9-14 (2005).
2. Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P. & Hu, F. B. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 121, 1356-1364 (2010).
3. Schulz, L. O. & Schoeller, D. A. A compilation of total daily energy expenditures and body weights in healthy adults. Am. J. Clin. Nutr. 60, 676-681 (1994).
4. Hammond, R. A. & Levine, R. The economic impact of obesity in the United States. Diabetes. Metab. Syndr. Obes. 3, 285-295 (2010).
5. O'Neill, S. & O'Driscoll, L. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes. Rev. 16, 1-12 (2015).
6. Bashan, N., Kovsan, J., Kachko, I., Ovadia, H. & Rudich, A. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol. Rev. 89, 27-71 (2009).
7. Furukawa, S. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114, 1752-1761 (2004).
8. Garber, C. E. et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor ftness in apparently healthy adults: Guidance for prescribing exercise. Med. Sci. Sports Exerc. 43, 1334-1359 (2011).
9. Hallal, P. C. et al. Global physical activity levels: Surveillance progress, pitfalls, and prospects. Lancet 380, 247-257 (2012).
10. Dumith, S. C., Hallal, P. C., Reis, R. S. & Kohl, H. W. Worldwide prevalence of physical inactivity and its association with human development index in 76 countries. Prev. Med. (Baltim). 53, 24-28 (2011).
11. Duncan, G. E. et al. Exercise Training, Without Weight Loss, Increases Insulin Sensitivity and Postheparin Plasma Lipase Activity in Previously Sedentary Adults. Diabetes Care 26, 557-562 (2003).
12. Nassis, G. P. et al. Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and infammatory markers in overweight and obese girls. Metabolism. 54, 1472-1479 (2005).
13. Lee, S. et al. Efects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes 61, 2787-2795 (2012).
14. Botezelli, J. D. et al. Exercise counteracts fatty liver disease in rats fed on fructose-rich diet. Lipids Health Dis. 9, 116 (2010).
15. Ghezzi, A. C. et al. Metabolic syndrome markers in wistar rats of diferent ages. Diabetol. Metab. Syndr. 4, 16 (2012).
16. Ribeiro, C. et al. Efects of physical training with diferent intensities of efort on lipid metabolism in rats submitted to the neonatal application of alloxan. Lipids Health Dis. 11, 138 (2012).
17. Krisan, A. D. et al. Resistance training enhances components of the insulin signaling cascade in normal and high-fat-fed rodent skeletal muscle. J. Appl. Physiol. 96, 1691-1700 (2004).
18. Kwon, H. R. et al. The efects of resistance training on muscle and body fat mass and muscle strength in type 2 diabetic women. Korean Diabetes J. 34, 101-110 (2010).
19. Botezelli, J. et al. Fructose-rich diet leads to reduced aerobic capacity and to liver injury in rats. Lipids in Health and Disease 11, 78 (2012).
20. Andreux, P. A. et al. Systems genetics of metabolism: the use of the BXD murine reference panel for multiscalar integration of traits. Cell 150, 1287-1299 (2012).
21. Vatansever-Ozen, S., Tiryaki-Sonmez, G., Bugdayci, G. & Ozen, G. The efects of exercise on food intake and hunger: Relationship with acylated ghrelin and leptin. J. Sport. Sci. Med. 10, 283-291 (2011).
22. Ropelle, E. R. et al. IL-6 and IL-10 anti-infammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol. 8; doi: 10.1371/journal.pbio.10000465 (2010).
23. Cauza, E. et al. The Relative Benefts of Endurance and Strength Training on the Metabolic Factors and Muscle Function of People With Type 2 Diabetes Mellitus. Arch. Phys. Med. Rehabil. 86, 1527-1533 (2005).
24. Mehran, A. E. et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab. 16, 723-737 (2012).
25. Shanik, M. H. et al. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31 Suppl 2, S262-S268 (2008).
26. Festa, A. et al. Chronic subclinical infammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102, 42-47 (2000).
27. Weiss, E. P. et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am. J. Clin. Nutr. 84, 1033-1042 (2006).
28. Kang, J. et al. Efect of exercise intensity on glucose and insulin metabolism in obese individuals and obese NIDDM patients. Diabetes Care 19, 341-349 (1996).
29. Almind, K. & Kahn, C. R. Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes 53, 3274-3285 (2004).
30. Dandona, P. Infammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25, 4-7 (2004).
31. Xu, H. et al. Chronic infammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003).
32. Marchesini, G. et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107, 450-455 (1999).
33. Dekerle, J., Baron, B., Dupont, L., Vanvelcenaher, J. & Pelayo, P. Maximal lactate steady state, respiratory compensation threshold and critical power. Eur. J. Appl. Physiol. 89, 281-288 (2003).
34. Billat, V. L., Sirvent, P., Py, G., Koralsztein, J. P. & Mercier, J. The concept of maximal lactate steady state: A bridge between biochemistry, physiology and sport science. Sport. Med. 33, 407-426 (2003).
35. Botezelli, J. D. et al. Diferent exercise protocols improve metabolic syndrome markers, tissue triglycerides content and antioxidant status in rats. Diabetol. Metab. Syndr. 3, 35 (2011).
36. Philp, A., Hamilton, D. L. & Baar, K. Signals mediating skeletal muscle remodeling by resistance exercise: PI3-kinase independent activation of mTORC1. J. Appl. Physiol. 110, 561-568 (2011).
37. Basciano, H., Federico, L. & Adeli, K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr. Metab. (Lond). 2, 5 (2005).
38. Loria, P. et al. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. Nutr. Metab. Cardiovasc. Dis. 17, 684-698 (2007).
39. Rector, R. S. et al. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G619-G626 (2008).
40. Krasnof, J. B., Painter, P. L., Wallace, J. P., Bass, N. M. & Merriman, R. B. Health-related ftness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 47, 1158-1166 (2008).
41. Kristiansen, O. P. & Mandrup-Poulsen, T. Interleukin-6 and diabetes the good, the bad, or the Indiferent? Diabetes 54, S114-S124 (2005).
42. Pedersen, B. K. & Febbraio, M. A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379-1406 (2008).
43. Pedersen, B. K. & Febbraio, M. A. Point: Interleukin-6 does have a benefcial role in insulin sensitivity and glucose homeostasis. J. Appl. Physiol. 102, 814-815 (2007).
44. Febbraio, M. A. & Pedersen, B. K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 16, 1335-1347 (2002).
45. McGillicuddy, F. C. et al. Interferon gamma attenuates insulin signaling, lipid storage, and diferentiation in human adipocytes via activation of the JAK/STAT pathway. J. Biol. Chem. 284, 31936-31944 (2009).
46. Wada, T. et al. Both type I and II IFN induce insulin resistance by inducing diferent isoforms of SOCS expression in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 300, E1112-E1123 (2011).
47. Shiba, T., Higashi, N. & Nishimura, Y. Hyperglycaemia due to insulin resistance caused by interferon-gamma. Diabet. Med. 15, 435-436 (1998).
48. Lawrence, T. The nuclear factor NF-kappaB pathway in infammation. Cold Spring Harb. Perspect. Biol. 1, a001651 (2009).
49. Schottelius, A. J. G., Mayo, M. W., Sartor, R. B. & Baldwin, A. S. Interleukin-10 Signaling Blocks Inhibitor of B Kinase Activity and Nuclear Factor B DNA Binding. J. Biol. Chem. 274, 31868-31874 (1999).
50. Murray, P. J. The primary mechanism of the IL-10-regulated antiinfammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA 102, 8686-8691 (2005).
51. de Moura, R. F., Ribeiro, C., de Oliveira, J. A., Stevanato, E. & de Mello, M. A. R. Metabolic syndrome signs in Wistar rats submitted to diferent high-fructose ingestion protocols. Br. J. Nutr. 101, 1178-1184 (2009).
52. Araújo, T. G. et al. High-fat diet based on dried bovine brain: an efective animal model of dyslipidemia and insulin resistance. J. Physiol. Biochem. 67, 371-379 (2011).
53. Bezerra, R. M. et al. A high-fructose diet induces insulin resistance but not blood pressure changes in normotensive rats. Braz. J. Med. Biol. Res. 34, 1155-1160 (2001).
54. Reeves, P. G., Nielsen, F. H. & Fahey, G. C. AIN-93 purifed diets for laboratory rodents: fnal report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123, 1939-1951 (1993).
55. Hickson, R. C. Interference of strength development by simultaneously training for strength and endurance. Eur. J. Appl. Physiol. Occup. Physiol. 45, 255-263 (1980).
56. Voltarelli, F. A., Gobatto, C. A. & de Mello, M. A. R. Determination of anaerobic threshold in rats using the lactate minimum test. Braz. J. Med. Biol. Res. 35, 1389-1394 (2002).
57. Rogatto, G. P. Infuência do Treinamento Físico Intenso Sobre o Metabolismo de Proteínas. 7, 75-82 (2001).
58. Senn, S. Analysis of serial measurements in medical research. BMJ 300, 680 (1990).
59. Middleton, J. E. Experience with a glucose-oxidase method for estimating glucose in blood and C. S. F. Br. Med. J. 1, 824-826 (1959).
60. Squadrito, G. & Cucinotta, D. The late complications of diabetes mellitus. Ann. Ital. Med. Int. 6, 126-136 (1991).